Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

American Kidney Fund Launches Disaster Relief Fund to Enhance its Rapid Response Program Helping Kidney Patients Affected by Disasters

ROCKVILLE, Md., May 21, 2025 (GLOBE NEWSWIRE) -- As the official start of hurricane season approaches on June 1, the American Kidney Fund (AKF) has created a new Disaster Relief Fund, an enhancement of AKF’s long-running Disaster Relief Program. For more than 30 years, AKF’s Disaster Relief Program has been the nation’s sole rapid-response system that provides emergency financial assistance to dialysis and recent transplant patients. By establishing the new Disaster Relief Fund, AKF can now also accept donations throughout the year, ensuring more funds are available when a disaster strikes. By fundraising year-round instead of on a per-disaster basis, AKF hopes to be able to administer more emergency grants to dialysis and post-transplant patients who have been impacted by natural disasters.

“Natural disasters can severely disrupt any person’s life, but for someone living with kidney failure or a kidney transplant, they bring greater risks and are more likely to have serious consequences,” said AKF President and CEO LaVarne A. Burton. “When disaster strikes, AKF swiftly activates its Disaster Relief Program to distribute grants to as many people in need as funds allow. With the creation of the Disaster Relief Fund, we aim to replenish our resources to prepare us for future disasters and help ensure we have enough funds to serve dialysis and post-transplant patients in need during emergencies.”

Disaster relief grants help patients with low incomes replace lost medications and kidney-friendly foods (which may be spoiled due to power outages), pay for temporary housing and transportation to treatment, and replace clothing and personal essentials lost due to the natural disaster or the need to evacuate with little to no notice. AKF covers the administrative costs of this program so that 100% of donations may go directly to patients in need.

While the Disaster Relief Fund will be active on an ongoing basis, the Disaster Relief Program will continue to only be activated after a major disaster occurs. The areas that are considered affected by a disaster are determined by information reported by the dialysis community and federal and state disaster declarations. If the funds are available, AKF then opens up the grant program to receive applications.

To date, the program has provided emergency financial support in communities nationwide during more than 20 life-altering disasters—including over $420,000 in 2024 in response to the Houston storms and Hurricanes Helene and Milton. To date in 2025, AKF has provided disaster relief to kidney patients affected by the California wildfires.

To find out more or donate in support of AKF’s Disaster Relief Fund, visit AKF’s website.

In addition to individual donors, AKF’s Disaster Relief Fund is supported by Akebia Therapeutics, Inc., Apellis Pharmaceuticals, Inc., Ardelyx, Inc., American Society of Nephrology, Aurinia Pharmaceuticals Inc., CorMedix, CSL Vifor, Foundation for Kidney Patients, Otsuka America Pharmaceutical, Inc., the Schattner Foundation and Travere Therapeutics, Inc.

###

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nonprofit with the greatest direct impact on people with kidney disease. AKF works on behalf of 1 in 7 Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. AKF fights for kidney health for all through programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and it has received 24 consecutive 4-Star ratings from Charity Navigator as well as the Platinum Seal of Transparency from Candid, formerly known as GuideStar.

For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn.


Nancy Gregory
American Kidney Fund
(240) 292-7077
ngregory@kidneyfund.org
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.